Breast cancer drug 'too costly' for NHS A life-extending breast cancer drug will not be routinely offered on the NHS in England and Wales because it is still too expensive, says the watchdog NICE. BBC News
See also:
See also:
- Kadcyla price still too high NICE
- Breast cancer drug Kadcyla is axed by NHS because of its cost The Daily Mail
- Postcode lottery for cancer drug as Nice rules Kadcyla too expensive The Guardian
- Breast cancer drug too expensive to be routinely available on NHS, watchdog rules The Independent
- Roche breast cancer drug at centre of UK pricing row Reuters
No comments:
Post a Comment